(Stroke. 1999;30:2720.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Laboratory for Cerebrovascular Disorders, National Cardio-Vascular Center Research Institute (H.Y., N.T., Z.Z.); the Department of Cerebrovascular Surgery (H.Y., I. Nagata, I. Nakahara); and the National Cardiovascular Center (H.K.), Osaka, Japan.
Correspondence to Hiroji Yanamoto, MD, DMSci, Laboratory for Cerebrovascular Disorders, National Cardio-Vascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, 565-8565 Japan. E-mail yanamoto{at}ri.ncvc.go.jp
| Abstract |
|---|
|
|
|---|
MethodsSixty-eight Sprague-Dawley rats were used. In group 1, ischemia and reperfusion were performed under normothermic (N) conditions (control, N-N). In group 2, ischemia was induced and maintained under hypothermic conditions (33°C for 2 hours) and reperfusion was performed under normothermic conditions, H-N. In group 3, both ischemia and reperfusion were performed under hypothermic conditions for an additional 21 hours after the surgery, H-22H. In group 4, ischemia was induced and maintained under hypothermic conditions and reperfusion was performed under hypothermic conditions only for the initial 3 hours (H-3H). In group 5, ischemia was induced and maintained under normothermic conditions and reperfusion was performed under hypothermic conditions (33°C) (N-22H). All rats were perfused 48 hours after the induction of ischemia. In addition, the normothermic or hypothermic therapy used for groups 1, 3, and 4 was performed again, and these rats were killed 30 days after the induction of ischemia. Furthermore, neurological deficits were monitored in groups N-N and H-22H for 4 weeks.
ResultsIn the H-3H and H-22H groups, the total infarct volume was significantly reduced by 41% or 66%, respectively, assessed 48 hours after ischemia. The significant reduction in group H-22H was again confirmed 30 days after ischemia, ie, 50% reduction was observed. In contrast, the reduction in group H-3H (31%) was not significant. The neurological deficits were significantly more severe in the N-N group than in the H-22H group during week 4.
ConclusionsThe neuroprotective effects against temporary focal ischemia evaluated by infarct volume and neurological functions by the combination therapy with intraischemic and prolonged postischemic mild hypothermia were persistent in rats. Appropriate design of mild hypothermia therapy extending into the late reperfusion period is important to maximize the neuroprotective effects of hypothermia.
Key Words: hypothermia cerebral infarction cerebral ischemia rats
| Introduction |
|---|
|
|
|---|
90% hippocampal CA1 neuroprotection was
achieved by 1 hourdelayed mild (32°C) postischemic
hypothermia for 24 hours, compared with only
15% neuroprotection by
1 hourdelayed postischemic hypothermia for 12
hours. The CA1 neuronal death was assessed 30 days after global ischemia
in gerbils. In temporary focal ischemia, we previously
demonstrated a significant (32%) reduction of the volume of cerebral
infarct on immediate and mild (32°C to 33°C)
postischemic hypothermia for 21 hours. In contrast, no
reduction was observed after immediate postischemic mild
hypothermia for only 1 hour, and only a small reduction (22%,
P=NS) on 30 minutesdelayed postischemic mild
hypothermia for 21 hours assessed 48 hours after the induction of
temporary focal ischemia in Sprague-Dawley
rats.7 The use of either intraischemic or prolonged postischemic hypothermia alone protects neurons from ischemic injury; however, it is unknown whether a combination of intraischemic and postischemic hypothermia provides further neuroprotection, and if so, whether the effects persist. Because of the technical complexity of establishing a reliable model of focal ischemia combined with prolonged temperature regulation under general anesthesia, few studies have been performed to clarify the efficacy of such combined hypothermia therapy. The present study was conducted to elucidate the effects of brief or prolonged mild postischemic hypothermia in combination with intraischemic mild hypothermia on neocortical infarct size or neurological deficits in a temporary focal ischemia model in rats.11
| Materials and Methods |
|---|
|
|
|---|
In an additional experiment, another 12 rats were divided into 2 groups (n=6 each), and cerebral functions (neurological deficits) after ischemia in normothermic or combined and prolonged mild hypothermic groups were analyzed as described below.
Surgical Protocols
All the rats had access to food and water ad libitum until
surgery. The surgical procedures used to induce temporary focal
neocortical ischemia were described in detail
elsewhere.11 Briefly, anesthesia was induced
with halothane in a mixture of oxygen and nitrogen. The right femoral
artery was cannulated in every rat to monitor mean arterial
blood pressure (model AP-611G, AP-600G, Nihon Kohden), assay blood
gases (PO2,
PCO2, pH; model ABL300, Radiometer
Copenhagen), and measure the concentration of blood sugar. The mean
arterial blood pressure was kept within 100 to 120
mm Hg by adjustment of the halothane concentration. A digital
thermometer was used to monitor rectal temperature beginning just
before MCA clipping; the temporal muscle temperature was
simultaneously monitored with a digital thermometer. Both
temperatures were controlled within 36.5°C to 37.5°C in the
normothermic condition and within 32.0°C to 33.0°C in
the hypothermic condition with a heating lamp or alcohol application to
the body surface during surgery. With a surgical microscope, both CCAs
were exposed, and a snare was placed loosely around each CCA with 5-0
nylon thread (PE50, Nippon Becton Dickinson). After the CCA snare had
been prepared and mechanical ventilation set up, the left MCA was
exposed by craniectomy and clipped with an arterial clip
(Sundt AVM Microclip No. 1, Codman) at the lateral border of the
olfactory tract. Immediately after the clipping of the MCA, the CCA
snares were pulled to occlude the CCAs. After 2 hours of 3-vessel
occlusion, the microclip was removed and the snares were released.
Reflow of the left MCA and both CCAs was confirmed visually during
surgery.
The experimental protocols were approved by the animal research committee at the National Cardiovascular Center Research Institute. All efforts were made to minimize suffering and the number of animals used.
Analyses of Infarct Volume
All animals were administered an overdose of sodium
pentobarbital and perfused intracardially with 200 mL of ice-cold
heparinized 10 mmol/L sodium phosphatebuffered saline (pH 7.5)
(PBS) at
110 to 140 mm Hg. The brain was removed, cut from the
frontal tip into slices 2 mm thick (RBM-4000C, ASI Inst), and
immersed in a 2% solution of
2,3,5-triphenyltetrazolium chloride (TTC).
The stained slices were then fixed by immersion in phosphate-buffered
4% paraformaldehyde/PBS. When the cerebral infarct was
assessed 48 hours after ischemia, the infarct area and
hemispheric areas of each section were traced under a stereomicroscope
and measured with an image-analysis system (SD-510C, Wacom). An
edema index was calculated by dividing the total volume of the
hemisphere ipsilateral to the MCA occlusion by the total volume of the
contralateral hemisphere.7 An infarct index, ie, the
actual infarct volume adjusted for edema, was calculated in each animal
as the total infarction volume divided by the edema index. When the
assessment of cerebral infarction was done at the chronic stage, 30
days after ischemia, the surviving neocortical area was
assessed by cresyl violet stain or TTC. The volume of the right normal
neocortex was measured and subtracted from the left neocortical volume
to calculate the total infarct volume, because the infarct-necrosis
area was completely liquefied and absorbed. Before the procedure of
paraffin-embedding of the brain slices, the shrinkage (rate) of the
brain by dehydration was measured in the right hemisphere to calculate
the absolute infarct volume. In addition, the gliosis that developed
within 30 days after the ischemic injury was visualized with
glial fibrillary acidic protein (GFAP) staining in the same brain
sections. In the measurement of the intact left neocortex by cresyl
violet at the chronic stage, the area of gliosis (developed in the
missing area) was excluded from the area of intact neocortex.
Analyses of Cerebral Functions
Neurological deficits were examined according to the scoring
scale described by Yamamoto et al,12 13 with modification,
2 days and 1, 2, 3, or 4 weeks after ischemia in the
normothermic (N-N) group and in the intra- and prolonged
(22 hours) postischemic hypothermia (H-22H) group.
Hemiplegia and posture while being lifted by the tail were graded
according to the following criteria: 0, no deficit (symmetrical
movement); 1, mild deficit (asymmetrical incomplete flexion of the
right forelimb or leftward-twisting tendency of the body); and 2,
severe deficit (asymmetrical complete flexion of the right forelimb or
repeated leftward body twisting). The neurological deficit score was
the sum of the hemiplegia and posture grades (from 0 to 4).
Statistics
Physiological data (ie, blood pressure,
gases, blood sugar concentration, and pH), regional cerebral blood flow
at each time point, infarct volumes, and infarct indexes were
analyzed by ANOVA. If multiple comparisons were indicated, the
Student-Newman-Keuls test was applied. The neurological deficit score
at each time point was analyzed by unpaired t test.
The results are presented as mean±SEM. A value of
P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
35°C to 36°C from 6 hours
after the reperfusion. Spontaneous hyperthermia (
38°C) was
observed in rats housed under normothermic conditions 6
hours beyond the induction of the temporary focal ischemia.
Forty-eight hours after the induction of ischemia, the core
temperatures were similar in all 4 groups.
|
Analyses of Cerebral Infarct
In the H-N, H-22H, and N-22H groups, 1 of the 7 rats in each group
died before an assessment of cerebral infarct 2 days after
ischemia. The autopsy of these 3 rats did not reveal any
abnormality capable of causing death. The cortical infarct that could
be assessed at the designated time was clearly demarcated as a pale
area, in contrast to the surrounding intact red area, when assessed 2
days after ischemia (Figure 3A
). In the additional
experiment, no rat died before the assessment 30 days after
ischemia.
|
The average infarct volumes for each group are shown in Figure 2
. The size of the cerebral infarct was
significantly reduced only by a combined therapy of
intraischemic and postischemic mild hypothermia.
There were significant differences between the control (N-N) and H-22H
or H-3H groups; ie, the combination therapy of intraischemic
and postischemic hypothermia was effective in reducing the
infarct volume. Although the average infarct volume in group H-22H was
smaller than that in group H-3H, the difference did not achieve
significance. The average infarct volume and the infarct index for each
group are shown in the Table
. The
significant differences observed in the infarct volumes among the
groups were also observed among the infarct indexes.
|
|
Thirty days after ischemia, the cerebral infarct lesion was
noted as a shrunken neocortex or a missing area in the neocortex
(Figure 3B
). In the border of the lesion
after necrosis, a thin layer of glial proliferation was observed
surrounding the GFAP-negative tissues (data not shown). The infarct
index obtained by cresyl violet stain (corrected by the shrinkage rate:
1.51 on average) is shown in Figure 4
.
The infarct index obtained by the TTC stain (before dehydration) is
shown in Figure 5
. The absolute infarct
values in each analysis were almost identical, ie, the
differences in the values derived by the 2 analyses (cresyl
violet and TTC) were 4, 3, or 1 mm3 on
average in the N-N, N-22H, or N-3H groups, respectively. In both
analyses of the cerebral infarct, there were significant
differences between groups N-N and H-22H but not between groups N-N and
H-3H.
|
|
Analyses of Cerebral Function
Severe neurological deficits were observed in the acute phase
after temporary focal ischemia in the normothermia (N-N) group
but were gradually recovered in the observation period (Figure 6
). In contrast, in the hypothermic group
(H-22H), no or slight neurological deficits were observed from the
acute phase after temporary focal ischemia and were
consistent throughout the whole observation period. There was a
significant difference in the neurological deficit scores at each time
point between the groups for 4 weeks after induction of
ischemia.
|
| Discussion |
|---|
|
|
|---|
To judge the neuroprotective effects, delayed assessment (1 to 6 months) of the ischemic neuronal injury has been considered important in global ischemia.8 Recently, a delayed development of cerebral infarction has been reported after mild focal ischemia.21 In the present study using temporary focal ischemia, when the effect of neuroprotection was assessed at a later time point (30 days after the onset), the significant reduction in group H-22H, a 66% reduction, observed on day 2 was found to have persisted, ie, 50% reduction was observed 30 days after ischemia. Conversely, 31% reduction was observed 30 days after ischemia in group H-3H, which was not significant compared with that of the normothermic control (group N-N). There was 10% to 16% growth of the neocortical infarct volume in 28 days (compared with the control infarct volume) after the combined mild hypothermia therapy. The results indicated that the significant neuroprotective effect on the infarct volume achieved with the combination of mild intraischemic and prolonged postischemic hypothermia therapy was not transient. Furthermore, functional impairments caused by temporary focal ischemia under normothermic conditions were also prevented by the combined prolonged hypothermic intervention.
It is unknown how hypothermic treatment protects neurons from lethal ischemic stress. When intraischemic hypothermia was applied, no significant difference was reported in high-energy phosphate depletion or in levels of lactate accumulation at the end of the ischemic insult.2 22 Several mechanisms regarding hypothermic brain protection have been postulated, including reduced release of glutamate,23 24 25 reduced incidence of spreading depression,26 improved regional cerebral blood flow during acute reperfusion,27 early restoration of inhibited protein synthesis,28 and decreased production of free radicals.29 30 Enhanced cerebrovascular permeability is reported after ischemia, and it was reported that intraischemic hypothermia reduced the abnormal enhancement of the blood-brain barrier permeability during and after ischemia.31 32 33 34 Furthermore, secondary elevation of the extracellular glutamate level or calcium-activated proteolysis in neurons during reperfusion after focal ischemia has been reported.35 36 The activation of protein kinase C during focal ischemia was reported, and it was suppressed by an application of moderate hypothermia in rats.37 We had observed that the activity of protein tyrosine phosphatase was irreversibly reduced in the ischemic core after reperfusion, and to a lesser extent in the penumbral area, and that both of these reductions were prevented by mild hypothermia treatment.38 The finding in this study was in line with those of others in which a prolonged period of hypothermia was important to achieve persistent neuroprotection.7 10 18 39 Some key enzymes that are essential for neurons to lead to death may be thermosensitive, ie, they are suppressed by mild hypothermia, and a prolonged inhibition of unknown (enzymatic) "death cascades" by intraischemic and postischemic hypothermia may cause an alteration of these reactions in different directions that results in neuronal survival. A prolonged inhibition of these reactions may ultimately interrupt the death cascades in neurons triggered by severe ischemic stress.
A gradual rewarming of the body temperature was strictly performed in the present treatment of prolonged hypothermia. A sudden elevation of the surrounding room temperature deteriorated the systemic condition, causing death, as mentioned in a previous report.7 Artificial temperature control for a prolonged period should be done with extremely careful observation to avoid any deteriorating complications and to achieve good outcomes.40
It has already been postulated that ischemic cerebral injury is an ongoing process from the induction of global ischemia through the acute reperfusion period.7 10 39 In the present study using temporary focal ischemia, mild and prolonged hypothermia therapy prevented neuronal death during ischemia and also prevented neuronal death processing during the reperfusion period. Ischemic brain attack (focal cerebral ischemia) in clinical situations is not always transient; however, induction of reperfusion for the occluded vessel with thrombolytic agents is the main therapeutic modality.41 42 43 44 In cases in which reperfusion is to be achieved, the application of mild hypothermia therapy initiated in the initial ischemic period has the potential to rescue a large part of the brain from the development of cerebral infarction. However, it is necessary to clarify the effects of prolonged mild hypothermia on permanent (not temporary) focal ischemia to be able to apply this strategy in the ultra-acute phase of stroke before the achievement of active reperfusion, because whether ongoing focal ischemia is transient when hypothermic therapy is initiated is unpredictable. Recently, a beneficial effect of mild prolonged hypothermia initiated at the acute phase after the diagnosis of cerebral infarct on severe permanent cerebral infarction in humans has been reported.45
| Acknowledgments |
|---|
Received July 12, 1999; revision received September 7, 1999; accepted September 7, 1999.
| References |
|---|
|
|
|---|
2. Busto R, Dietrich WD, Globus MYT, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987;7:729738.[Medline] [Order article via Infotrieve]
3. Welsh FA, Sims RE, Harris VA. Mild hypothermia prevents ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab. 1990;10:557563.[Medline] [Order article via Infotrieve]
4. Goto Y, Kassell NF, Hiramatsu K, Soleau S, Lee KS. Effect of intraischemic hypothermia on cerebral damage in a model of reversible focal ischemia. Neurosurgery. 1993;32:980985.[Medline] [Order article via Infotrieve]
5. Morikawa E, Ginsberg MD, Dietrich WD, Duncan RC, Kraydieh S, Globus MYT, Busto R. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1992;12:380389.[Medline] [Order article via Infotrieve]
6.
Ridenour TR, Warner DS, Todd MM, McAllister AC.
Mild hypothermia reduces infarct size resulting from temporary but not
permanent focal ischemia in rats. Stroke. 1992;23:733738.
7. Yanamoto H, Hong S, Soleau S, Kassell NF, Lee KS. Mild postischemic hypothermia limits cerebral injury following transient focal ischemia in rat neocortex. Brain Res. 1996;718:207211.[Medline] [Order article via Infotrieve]
8. Colbourne F, Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci. 1995;15:72507260.[Abstract]
9. Colbourne F, Sutherland G, Corbett D. Postischemic hypothermia: a critical appraisal with implications for clinical treatment. Mol Biol. 1997;14:171201.
10. Colbourne F, Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 1994;654:265272.[Medline] [Order article via Infotrieve]
11. Yanamoto H, Nagata I, Hashimoto N, Kikuchi H. Three-vessel occlusion using a micro-clip for the proximal left middle cerebral artery produces a reliable neocortical infarct in rats. Brain Res Protoc. 1998;3:209220.[Medline] [Order article via Infotrieve]
12.
Yamamoto M, Tamura A, Kirino T, Hirakawa M,
Shimizu M, Sano K. Effect of a new thyrotropin-releasing hormone
analogue administered in rats 1 week after middle cerebral artery
occlusion. Stroke. 1989;20:10891091.
13. Yamamoto M, Tamura A, Kirino T, Shimizu M, Sano K. Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats. Brain Res. 1988;452:323328.[Medline] [Order article via Infotrieve]
14. Xue D, Huang ZG, Smith KE, Buchan AM. Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Res. 1992;587:6672.[Medline] [Order article via Infotrieve]
15. Barone FC, Feuerstein GZ, White RF. Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci Biobehav Rev. 1997;21:3144.[Medline] [Order article via Infotrieve]
16. Zhang ZG, Chopp M, Chen H. Duration dependent post-ischemic hypothermia alleviates cortical damage after transient middle cerebral occlusion in the rat. J Neurol Sci. 1993;117:240244.[Medline] [Order article via Infotrieve]
17.
Zhang RL, Chopp M, Chen H, Gracia JH, Zhang ZG.
Postischemic (1 hour) hypothermia significantly reduces
ischemic cell damage in rats subjected to 2 hours of middle
cerebral artery occlusion. Stroke. 1993;24:12351240.
18. Dietrich WD, Busto R, Alonso O, Globus MY, Ginsberg MD. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab. 1993;13:541549.[Medline] [Order article via Infotrieve]
19. Welsh FA, Harris VA. Postischemic hypothermia fails to reduce ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab. 1991;11:617620.[Medline] [Order article via Infotrieve]
20. Buchan A, Pulsinelli WA. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci. 1990;10:311316.[Abstract]
21. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab. 1996;16:195201.[Medline] [Order article via Infotrieve]
22.
Natale JE, DAlecy LG. Protection from cerebral
ischemia by brain cooling without reduced lactate accumulation
in dogs. Stroke. 1989;20:770777.
23. Busto R, Globus MYT, Dietrich WD, Martinez E, Valdés I, Ginsberg MD. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke. 1989;20:904910.
24. Mitani A, Kataoka K. Critical levels of extracellular glutamate mediating gerbil hippocampal delayed neuronal death during hypothermia: brain microdialysis study. Neuroscience. 1991;42:661670.[Medline] [Order article via Infotrieve]
25. Huang F, Zhou L, Yang G. Effects of mild hypothermia on the release of regional glutamate and glycine during extended transient focal cerebral ischemia in rats. Neurochem Res. 1998;23:991996.[Medline] [Order article via Infotrieve]
26. Chen Q, Chopp M, Bodzin G, Chen H. Temperature modulation of cerebral depolarization during focal cerebral ischemia in rats: correlation with ischemic injury. J Cereb Blood Flow Metab. 1993;13:389394.[Medline] [Order article via Infotrieve]
27. Jiang Q, Chopp M, Zhang ZG, Helpern JA, Ordidge RJ, Ewing J, Jiang P, Marchese BA. The effect of hypothermia on transient focal ischemia in rat brain evaluated by diffusion- and perfusion-weighted NMR imaging. J Cereb Blood Flow Metab. 1994;14:732741.[Medline] [Order article via Infotrieve]
28. Widmann R, Miyazawa T, Hossmann K-A. Protective effect of hypothermia on hippocampal injury after 30 minutes of forebrain ischemia in rats is mediated by postischemic recovery of protein synthesis. J Neurochem. 1993;61:200209.[Medline] [Order article via Infotrieve]
29. Globus MY-T, Busto R, Lin B, Schnippering H, Ginsberg MD. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J Neurochem. 1995;65:12501256.[Medline] [Order article via Infotrieve]
30. Kil HY, Zhang J, Piantadosi CA. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J Cereb Blood Flow Metab. 1996;16:100106.[Medline] [Order article via Infotrieve]
31. Dietrich WD, Busto R, Halley M, Valdes I. The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. J Neuropathol Exp Neurol. 1990;49:486497.[Medline] [Order article via Infotrieve]
32. Karibe H, Zarow GJ, Graham SH, Weinstein PR. Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1994;11:261271.
33. Krantis A. Hypothermia-induced reduction in the permeation of radiolabelled tracer substances across the blood-brain barrier. Acta Neuropathol (Berl). 1983;60:6169.[Medline] [Order article via Infotrieve]
34. Yanamoto H, Hashimoto N, Kassell NF, Lee NS. Disruption of blood brain barrier triggered by reperfusion following transient focal ischemia in rats. Soc Neurosci Abst. 1996;22:838.3. Abstract.
35. Matsumoto K, Lo EH, Pierce AR, Halpern EF, Newcomb R. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J Cereb Blood Flow Metab. 1996;16:114124.[Medline] [Order article via Infotrieve]
36. Hong S-C, Lanzino G, Goto Y, Kang SK, Schottler F, Kassell NF, Lee KS. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res. 1994;661:4350.[Medline] [Order article via Infotrieve]
37. Tohyama Y, Sako K, Yonemasu Y. Hypothermia attenuates the activation of protein kinase C in focal ischemic rat brain: dual autoradiographic study of [3H]phorbol 12, 13-dibutyrate and iodo[14C]antipyrine. Brain Res. 1998;782:348351.[Medline] [Order article via Infotrieve]
38. Yanamoto H, Kassell NF, Okonkwo DO, Soleau S, Dennis J, Lee KS. Regional modifications in phosphotyrosine phosphatase activity after transient focal ischemia in rat brain. J Cereb Blood Flow Metab. 1995;15:S331. Abstract.
39.
Coimbra C, Drake M, Boris-Moller F, Wieloch T.
Long-lasting neuroprotective effect of postischemic
hypothermia and treatment with an anti-inflammatory/antipyretic drug:
evidence for chronic encephalopathic processes following
ischemia. Stroke. 1996;27:15781585.
40. Schubert A. Side effects of mild hypothermia. J Neurosurg Anesthesiol. 1995;7:139147.[Medline] [Order article via Infotrieve]
41.
Brott T, Haley EC, Levy DE, Barsan W, Broderick
J, Sheppard G, Spilker J, Kongable G, Reed R, Marler J. Urgent therapy
for stroke, I: pilot study of tissue plasminogen
activator administered within 90 minutes.
Stroke. 1992;23:632640.
42.
Haley EC, Levy DE, Brott TG, Sheppard GL, Wong
WCW, Kongable GL, Torner JC, Marler JR. Urgent therapy for stroke, II:
pilot study of tissue plasminogen activator
administered 90180 minutes from onset. Stroke. 1992;23:641645.
43.
The National Institute of Neurological Disorders,
and Stroke rt-PA Stroke Study Group. Tissue plasminogen
activator for acute ischemic stroke. N
Engl J Med. 1995;333:15811587.
44.
The National Institute of Neurological Disorders,
and Stroke (NINDS) rt-PA Stroke Study Group. Generalized efficacy of
t-PA for acute stroke: subgroup analysis of the NINDS t-PA
stroke trial. Stroke. 1997;28:21192125.
45.
Schwab S, Schwarz S, Spranger M, Keller E,
Bertram M, Hacke W. Moderate hypothermia in the treatment of patients
with severe middle cerebral artery infarction. Stroke. 1998;29:24612466.
Center for Clinical and Molecular Neurobiology, Departments of Neurology and Neuroscience, University of Minnesota, Minneapolis, Minnesota
| Introduction |
|---|
|
|
|---|
The present preclinical results have important implications for clinical studies on the therapeutic effect of hypothermia in stroke patients. For example, the findings suggest that hypothermia has to be instituted early after the onset of ischemia. Therefore, future studies should make an effort to lower body temperature early in the course of the stroke. Furthermore, long-lasting protection is observed only when the temperature is lowered for a prolonged period of time. Prolonged hypothermia is likely to increase the risk of complications, such as pneumonia, that have been observed in stroke patients in whom brain temperature was lowered for 2 to 3 days.2
There are other factors that need to be considered. In patients with MCA occlusion and increased intracranial pressure, hypothermia (33°C) for 2 to 3 days after stroke reduced intracranial pressure.2 However, 11 of 25 patients (44%) herniated and died of massive cerebral edema that developed during the rewarming period.2 This is a serious complication that is not routinely encountered in rodent studies. Studies of severe focal ischemia in larger animals, including primates, may help clarify the mechanisms of this devastating complication that may prove to be an obstacle to the use of hypothermia in patients with ischemic stroke.
Received July 12, 1999; revision received September 7, 1999; accepted September 7, 1999.
| References |
|---|
|
|
|---|
2. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke.. 1998;29:24612466.
3.
Schwab S, Spranger M, Aschoff A, Steiner T, Hacke
W. Brain temperature monitoring and modulation in patients with severe
MCA infarction. Neurology.. 1997;48:762767.
This article has been cited by other articles:
![]() |
B. P. Meloni, F. L. Mastaglia, and N. W. Knuckey Review: Therapeutic applications of hypothermia in cerebral ischaemia Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 75 - 98. [Abstract] [PDF] |
||||
![]() |
H. B. van der Worp, E. S. Sena, G. A. Donnan, D. W. Howells, and M. R. Macleod Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis Brain, December 1, 2007; 130(12): 3063 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Krieger and M. A. Yenari Therapeutic Hypothermia for Acute Ischemic Stroke: What Do Laboratory Studies Teach Us? Stroke, June 1, 2004; 35(6): 1482 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zausinger, K. Scholler, N. Plesnila, and R. Schmid-Elsaesser Combination Drug Therapy and Mild Hypothermia After Transient Focal Cerebral Ischemia in Rats Stroke, September 1, 2003; 34(9): 2246 - 2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Dae, D. W. Gao, P. C. Ursell, C. A. Stillson, and D. I. Sessler Safety and Efficacy of Endovascular Cooling and Rewarming for Induction and Reversal of Hypothermia in Human-Sized Pigs Stroke, March 1, 2003; 34(3): 734 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kollmar, W.R. Schabitz, S. Heiland, D. Georgiadis, P.D. Schellinger, J. Bardutzky, and S. Schwab Neuroprotective Effect of Delayed Moderate Hypothermia After Focal Cerebral Ischemia: An MRI Study Stroke, July 1, 2002; 33(7): 1899 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Macoviak, J. Hwang, K. L. Boerjan, and D. D. Deal Comparing dual-stream and standard cardiopulmonary bypass in pigs Ann. Thorac. Surg., January 1, 2002; 73(1): 203 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mustafa and O. Thulesius Cooling-Induced Carotid Artery Dilatation: An Experimental Study in Isolated Vessels Stroke, January 1, 2002; 33(1): 256 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Krieger, M. A. De Georgia, A. Abou-Chebl, J. C. Andrefsky, C. A. Sila, I. L. Katzan, M. R. Mayberg, and A. J. Furlan Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke Stroke, August 1, 2001; 32(8): 1847 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yanamoto, I. Nagata, Y. Niitsu, Z. Zhang, J.-H. Xue, N. Sakai, H. Kikuchi, and C. Iadecola Prolonged Mild Hypothermia Therapy Protects the Brain Against Permanent Focal Ischemia Editorial Comment Stroke, January 1, 2001; 32(1): 232 - 239. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |